Literature DB >> 21235329

Selective vulnerability of non-myelinated axons to stretch injury in an in vitro co-culture system.

Jerome A Staal1, James C Vickers.   

Abstract

Diffuse axonal injury (DAI) is an evolving axonopathy commonly characterized clinically as widespread damage to the white matter tracts. In recent electrophysiological studies, researchers have proposed that myelinated and unmyelinated axons differ in their vulnerability and functional recovery following DAI. In this study we present for the first time an in vitro stretch-injury approach that utilizes a novel myelinating co-culture system to determine the differential response between myelinated and non-myelinated axon bundles to injury. In implementing this technique we demonstrate that myelinated axon bundles are less vulnerable to stretch injury compared to caliber-matched non-myelinated bundles. Interestingly, moderate axonal strain did not induce demyelination, but instead caused an increase in the proportion of degenerated myelin basic protein over time. Additionally, there were no significant differences in the expression of axonal swellings, which is indicative of disrupted axonal transport. In summary, we present an ideal in vitro model that permits further mechanistic investigations into the role of myelin and oligodendrocyte-neuron interactions in response to DAI.

Entities:  

Mesh:

Year:  2011        PMID: 21235329     DOI: 10.1089/neu.2010.1658

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  16 in total

1.  Partial interruption of axonal transport due to microtubule breakage accounts for the formation of periodic varicosities after traumatic axonal injury.

Authors:  Min D Tang-Schomer; Victoria E Johnson; Peter W Baas; William Stewart; Douglas H Smith
Journal:  Exp Neurol       Date:  2011-11-04       Impact factor: 5.330

Review 2.  Axonal pathology in traumatic brain injury.

Authors:  Victoria E Johnson; William Stewart; Douglas H Smith
Journal:  Exp Neurol       Date:  2012-01-20       Impact factor: 5.330

Review 3.  The young brain and concussion: imaging as a biomarker for diagnosis and prognosis.

Authors:  Esteban Toledo; Alyssa Lebel; Lino Becerra; Anna Minster; Clas Linnman; Nasim Maleki; David W Dodick; David Borsook
Journal:  Neurosci Biobehav Rev       Date:  2012-03-28       Impact factor: 8.989

4.  A novel closed-body model of spinal cord injury caused by high-pressure air blasts produces extensive axonal injury and motor impairments.

Authors:  Nobel del Mar; Xinyu von Buttlar; Angela S Yu; Natalie H Guley; Anton Reiner; Marcia G Honig
Journal:  Exp Neurol       Date:  2015-05-07       Impact factor: 5.330

5.  Therapy development for diffuse axonal injury.

Authors:  Douglas H Smith; Ramona Hicks; John T Povlishock
Journal:  J Neurotrauma       Date:  2013-02-14       Impact factor: 5.269

6.  SNTF immunostaining reveals previously undetected axonal pathology in traumatic brain injury.

Authors:  Victoria E Johnson; William Stewart; Maura T Weber; D Kacy Cullen; Robert Siman; Douglas H Smith
Journal:  Acta Neuropathol       Date:  2015-11-20       Impact factor: 17.088

Review 7.  Mechanosensation in traumatic brain injury.

Authors:  Carolyn E Keating; D Kacy Cullen
Journal:  Neurobiol Dis       Date:  2020-11-28       Impact factor: 5.996

Review 8.  Diffuse axonal injury in brain trauma: insights from alterations in neurofilaments.

Authors:  Declan G Siedler; Meng Inn Chuah; Matthew T K Kirkcaldie; James C Vickers; Anna E King
Journal:  Front Cell Neurosci       Date:  2014-12-17       Impact factor: 5.505

Review 9.  Catecholamines and cognition after traumatic brain injury.

Authors:  Peter O Jenkins; Mitul A Mehta; David J Sharp
Journal:  Brain       Date:  2016-06-02       Impact factor: 13.501

10.  Intrinsically photosensitive retinal ganglion cell-driven pupil responses in patients with traumatic brain injury.

Authors:  Jakaria Mostafa; Jason Porter; Hope M Queener; Lisa A Ostrin
Journal:  Vision Res       Date:  2021-08-02       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.